drugset / Trial / NCT06054100

The Effect of Colchicine on Inflammation in ACS Patients

NCT06054100

Phase 3 Completed 88 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindPrevention

Summary

This study will evaluate whether the anti-inflammatory effect of colchicine is beneficial in ACS patients

Timeline

Start
2020-02-01
Primary completion
2022-02-15
Completion
2022-05-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.5 mg Oral